Mark White

2.0k citations

29 papers · 1.4k indexed · 1 hit paper · h-index 17

Impact in

Immunology top 5%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Psoriasis: Treatment and Pathogenesis
Microbiology top 5%
- Antimicrobial Peptides and Activities

Papers in

Immunology 14
- Immune Response and Inflammation 9
- Psoriasis: Treatment and Pathogenesis 3
Molecular Medicine 2
- Antibiotic Resistance in Bacteria 2

Co-authors: Patrick J. Scannon Stephen F. Carroll John P. Pribble Jean‐Louis Vincent Steven M. Opal Jon H. Lemke Nicolas A. Parejo John E. Palardy
Journals: Shock (2 papers)Journal of Cutaneous Medicine and Surgery (2 papers)The Journal of Clinical Pharmacology (2 papers)The Journal of Infectious Diseases (2 papers)The Pediatric Infectious Disease Journal (2 papers)
Partner nations: United States Netherlands Russia

In The Last Decade

Mark White

28 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock 1999 · 505 citations

Peers

Countries citing papers authored by Mark White

Since Specialization

Citations

This map shows the geographic impact of Mark White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark White more than expected).

Fields of papers citing papers by Mark White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark White. The network helps show where Mark White may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark White, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark White Line = papers co-authored together Mark White links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Selective Allosteric Antibodies to the Insulin Receptor for the Treatment of Hyperglycemic and Hypoglycemic Disorders Journal of Diabetes Science and Technology ·Hassan Issafras, Daniel Bedinger, John Corbin, Ira D. Goldfine, Vinay Bhaskar, Mark White, Paul Rubin, Patrick J. Scannon	2014	21
2	Shoulder sores in sows Mark White	2008	0
3	An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis The Journal of Clinical Pharmacology ·Amita Joshi, Robert J. Bauer, Peter Kuebler, Mark White, T. Kulinich, Peter G. Compton, Marvin R. Garovoy, Paul Kwon, Patricia A. Walicke, Russell L. Dedrick	2006	52
4	Endotoxemia and elevation of lipopolysaccharide-binding protein after hematopoietic stem cell transplantation The Pediatric Infectious Disease Journal ·Ofer Levy, Armando Teixeira‐Pinto, Mark White, Stephen F. Carroll, Leslie Lehmann, David Wypij, Eva C. Guinan	2003	15
5	Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis Journal of Cutaneous Medicine and Surgery ·Alice B. Gottlieb, Bruce Miller, Nicholas J. Lowe, William Shapiro, T.S Al-Juobory, Christie Dr, Mark Ling, Jaqueline Bressan, Calvin O. McCall, Tirta Ayu Retno Sari, Wolfgang Dummer, Patricia A. Walicke, Robert J. Bauer, Mark White, Marvin R. Garovoy	2003	28
6	Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis Journal of Cutaneous Medicine and Surgery ·Alice B. Gottlieb, Bruce Miller, Nicholas J. Lowe, William Shapiro, T.S Al-Juobory, Christie Dr, Mark Ling, Jaqueline Bressan, Calvin O. McCall, Tirta Ayu Retno Sari, Wolfgang Dummer, Patricia A. Walicke, Robert J. Bauer, Mark White, Marvin R. Garovoy	2003	4
7	Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils1 Transplantation ·Ofer Levy, Richard B. Sisson, Thomas Janson, Donald A. Goldmann, Erika V. Valore, Tomas Ganz, Mark White, Stephen F. Carroll, Leslie Lehmann, Eva C. Guinan	2002	10
8	Preoperative and Postoperative Endotoxemia in Children With Congenital Heart Disease CHEST Journal ·Laurance Lequier, Hisashi Nikaidoh, Steven Leonard, V. E. Grankin, Mark White, Patrick J. Scannon, Brett P. Giroir	2000	83
9	Gender differences in blood levels, but not brain levels, of ethanol in rats. PubMed ·Mark Johnson, Mark White, Margaret George, Jason N. Jaworski, Lane J. Brunner, Francine E. Lancaster, Rueben A. Gonzales	1999	55
10	Population Pharmacokinetics and Pharmacodynamics of the Anti-CD11a Antibody hu1124 in Human Subjects with Psoriasis Journal of Pharmacokinetics and Biopharmaceutics ·Robert J. Bauer, Russell L. Dedrick, Mark White, Michael J. Murray, Marvin R. Garovoy	1999	102
11	Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock The Journal of Infectious Diseases ·Steven M. Opal, Patrick J. Scannon, Jean‐Louis Vincent, Mark White, Stephen F. Carroll, John E. Palardy, Nicolas A. Parejo, John P. Pribble, Jon H. Lemke Hit paper breakdown →	1999	505
12	PHARMACOKINETICS OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/PERMEABILITY INCREASING PROTEIN (rBPI21) AFTER LIVER SURGERY IN RATS AND HUMANS Shock ·Marinus J. Wiezer, Н. М. Качалова, Gregory Barnes, Robert J. Bauer, Mark White, Stephen F. Carroll, Sybren Meyer, L. G. Thijs, Paul A.M. van Leeuwen	1998	15
13	A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/ PERMEABILITY-INCREASING PROTEIN IN HEALTHY MALE VOLUNTEERS Shock ·Robert J. Bauer, Mark White, Nancy Wedel, Betty J Nelson, N. Friedmann, Albert Cohen, W N M Hustinx, Ada H. C. Kung	1996	23
14	Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndrome The Pediatric Infectious Disease Journal ·Hector R. Wong, Lesley Doughty, Nancy Wedel, Mark White, Betty J Nelson, R�mulo Guerrero Vicu�a, Joseph A. Carcillo	1995	17
15	Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein The Journal of Infectious Diseases ·Jeremy Moreau, A N Kimmings, Nancy Wedel, Marcel L.C.M. Mevissen, J. Jansen, N. Friedmann, Todd J. Lorenz, Betty J Nelson, Mark White, Robert J. Bauer, C. Erik Hack, A. J. M. Eerenberg, Sander J. H. van Deventer	1995	98
16	Continuous Infusion Animal Model for the Immunoconjugate Xomazyme-CD5 Plus, in the Rat Journal of the American College of Toxicology ·Ada H. C. Kung, Nevein Hasanein, Mohammed A Yinusa, Virginia L. Mohler, Mark White	1994	2
17	Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA Journal of Immunological Methods ·Mark White, Martha dos Reis, C Birr, Patrick W. Trown, Stephen F. Carroll	1994	37
18	In vitro high resolution ¹h‐spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma Magnetic Resonance in Medicine ·Mark L. Schiebler, 修海老塚, Mark White, Susan J. Maygarden, James L. Mohler	1993	63
19	Development of a new human breast cancer cell line Ia-270 Breast Cancer Research and Treatment ·Reza Mohamad dost, Gerald H. Clamon, John H. MacIndoe, Mark White, Luis F. Urdaneta, Bharati Hukku, William Peterson	1985	2
20	Establishment and characterization of four new human non-small cell lung cancer cell lines. PubMed ·Reza Mohamad dost, Gerald H. Clamon, Robert A. Robinson, Mark White, Bharati Hukku, Nicholas P. Rossi, William Peterson	1984	21

About Mark White

Mark White is a scholar working on Immunology, Molecular Medicine, Biotechnology, Pharmacology and Periodontics, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Response and Inflammation (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Cancer Research and Treatments (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Immunology (568 citations), Microbiology (118 citations), Critical Care and Intensive Care Medicine (52 citations), Epidemiology (320 citations) and Radiology, Nuclear Medicine and Imaging (191 citations). Mark White has collaborated with scholars based in United States, Netherlands and Russia. Frequent co-authors include Patrick J. Scannon, Stephen F. Carroll, John P. Pribble, Jean‐Louis Vincent, Steven M. Opal, Jon H. Lemke, Nicolas A. Parejo, John E. Palardy, Robert J. Bauer and Marvin R. Garovoy. Their work appears in journals such as Shock, Journal of Cutaneous Medicine and Surgery, The Journal of Clinical Pharmacology, The Journal of Infectious Diseases and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact